Exclusive Licensing Agreement for CAR T Cell, TCR, NK Cell Programs and Associated Technologies for the Development of Non-Viral Adoptive Cellular Therapies
Combined Technologies to Leapfrog Clinical Pipeline of Next Generation Therapies Using Synthetic and Personalized Immunology GERMANTOWN, Md.
Sign-up for Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative investment picks
Sign-up for Mylan receives tentative FDA approval for pediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative investment picks
By Russ Britt, MarketWatch
Boston Scientific turning around, up more than 4% on upgrade
LOS ANGELES (MarketWatch)-- A slew of stock upgrades, improved outlooks, positive drug trials and an overall market rally boosted the health-care sector Thursday.
By Wallace Witkowski, MarketWatch
SAN FRANCISCO (MarketWatch)--Earnings from the energy and health care sectors will dominate investor attention as respective heavyweights report following a week where upside earnings surprises lifted the broader market out of a slump.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.